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doi:10.1016/j.ejvs.2010.11.013Abstract Objectives: Wounds of the lower limb in patients with diabetes are frequently diffi-
cult to heal. Some wounds fail to heal despite optimal medical and surgical care. This review
examines the evidence for whether free tissue transfer techniques may reduce the require-
ment of amputation in these patients.
Design: A systematic review.
Materials & Methods: Pubmed, Embase, AMED, SCOPUS and CINAHL and Cochrane Library were
searched for all articles on free tissue transfer in lower limb wounds in patients with diabetes
(September 2010). Current experience, indications and outcomes were analysed.
Results: 528 patients from 18 studies were included in the systematic review. 66% of patients
had concomitant revascularisation with bypass surgery. 63% of flaps were muscle based, 35%
fasciocutaneous and 1.7% omental. Pooled in-hospital mortality rate was 4.4%, flap survival
was 92% and limb salvage rate of 83.4% over a 28 months average follow-up time.
Conclusions: In conclusion free tissue transfer achieves successful wound healing in selected
patients with diabetes and difficult to heal wounds that would have required amputation.
Pre-operative optimisation of vascular supply and eradication of infection is key to success.
Objective wound assessment scores and a clear multidisciplinary team (MDT) approach would
improve patient care.
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At present there are estimated to be 55 million people in
Europe with diabetes.1 Up to 15% of these will develop
a foot ulcer during their life.2 Patients with diabetes who
develop foot ulcers have increased mortality compared
with those who have intact feet (15% lower survival at 3
years)3, a reduced quality of life and are more likely to
require amputation.4,5
With specialist multidisciplinary care, including wound
debridement, treatment of infection, off-loading and revas-
cularisation, some two-thirds of patients with diabetes who
develop an ulcer will eventually heal their foot.6,7 This
process is expensive and takes on average two months.8 One-
third of patients’ wounds will not heal and these patients are
at high risk of amputation. Identification of this group at
presentation of an ulcer has been improved by the validation
of scoring systems.9 Itmaybe thesepatientswhobenefitmost
from reconstructive surgery to heal their wounds and save
their legs.
Surgeons have used free tissue transfer to heal large,
complex wounds since the late 1970’s.10 However, their use
in patients with diabetic foot ulcers has been less well
documented. This systematic review of the literature is
concerned with the indications and outcomes of free tissue
transfer in patients with diabetes and non-traumatic lower
limb wounds.
Methods
A systematic review of the literature was performed using
the MEDLINE, EMBASE, AMED, SCOPUS and CINAHL data-
bases (1966eSeptember 2010). Free-text search terms
‘free flap & diabetes’, ‘limb salvage & diabetes, ‘revascu-
larisation & flap & diabetes’, and ‘free tissue transfer &
diabetes’ and Medical Subject Headings (MeSH) ‘free flap’Figure 1 PRISMA flowchart des(MeSH) and ‘diabetes’ (MeSH) were used in combination
with the Boolean operators AND or OR. In addition other
studies were identified from cited references during
a bibliography search of reviewed articles. The Current
Controlled Trials Register (http://www.controlled-trials.
com), the DARE database and the Cochrane Database of
Controlled Trials were also interrogated. Studies in which
trauma patients accounted for more than 15% of the study
numbers were excluded. All articles that reported the use
of free flap surgery in lower limb diabetic disease and
peripheral vascular disease were included for abstract
review. Case reports and technical descriptions were
excluded. The literature review conformed to PRISMA
statement standards.11,12
Quality assessment of retrieved articles identified, 4
prospective case series and 14 retrospective case series
(Fig. 1). There were no controlled studies. The data was
summarized and pooled estimates and averages were
calculated where possible.
In total 1235 citations from databases where found.
A review of bibliographies yielded a further 15 citations.
1204 abstracts or titles were rejected because they did
not primarily deal with chronic or diabetic lower limb
wounds. 46 articles were obtained in full, providing
a total of 18 to be included in the review. The search
protocol and article selection was completed by one
author (EFOC).
Results
A total of 18 selected papers gave details on 543 free tissue
transfers for limb salvage in a combined total of 528
patients. 85% (n Z 449) of the total patients had diabetes.
Where described, mean average is used along with the 95%
confidence intervals. Study sizes ranged from 9 to 79 cases.
The largest study accounts for 14.5% of all patients13 a totalcribing the literature search.
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for all studies was 63 months (range 12e180 months), with
a pooled average 6.44 operations per year in each reporting
centre.
14 of the 18 studies included are retrospective case
series reports.13e26 Data on the number of patients
considered (and turned down) for free flap surgery was
presented in one study only. In that study a total of 287
consecutive patients were assessed for suitability for free
flap reconstruction. Only 71 (25%) were deemed suitable
and operated on. The reason for deeming 216 non-
salvageable was not fully reported. Two studies revealed
the number of lower limb bypasses requiring free tissue
transfer; 15 out of total 465 (3%),22 and 27 out of 297 (9%).14
The other studies presented inclusion and exclusion criteria
in general terms only.
Patient characteristics
From the 18 studies there were 528 patients with a mean
age of 59 years, (range 18e85). Information on the gender
of patients was available from 15 studies13e17,19,21e29 of
which 72% were male. Follow-up ranged from 1 month to
180 months, whilst the average hospital stay was 35 days
(range 15e70). There was little data on type of diabetes
(type 1 or 2) and insulin use. Patients across all studies were
chosen on the basis of having chronic non-healing ulcers.
Four studies specifically mentioned the failure of conser-
vative management and wounds which showed no sign of
healing following thorough debridement. Absolute contra-
indications included renal failure in 2 studies,24,26 and
ankle-brachial pressure index minimal values in a further 2
studies.16,23 Authors had broad inclusion criteria for
surgery, such as good glycemic control and no majorTable 1 Inclusion criteria by study.
Study Patients
(N )
Non healing lower
leg wound & failure
of conservative
management
Previously
mobile
Czerny et al.27 25 O
Drazan et al.30 13 O
Gooden et al.14 26 O O
Hong15 71 O
Karp et al.16 19 O
Kim et al.28 15 O
Lai et al.17 9 O
McCarthy et al.29 21 O
Moran et al.18 75 O O
Moucharafieh et al.19 10 O
Oishi et al.20 19 O O
Ozkan et al.21 13 O
Quin˜ones-Baldrich
et al.22
15 O
Rainer et al.23 10 O O
Randon et al.24 76 O O
Sunar et al.25 14 O O
Tukiainen et al.13 79 O O
Verhelle et al.26 19 O Osystemic illness, amongst others (Table 1). All patients
underwent preoperative assessment and planning with
angiography. There was a variety of other preoperative
assessments conducted (Table 2). One study stipulated the
involvement of a multidisciplinary team in the selection
and assessment of patients15 but there was no mention of
the component specialists involved.
Wound characteristics
None of the studies used validated wound scoring systems
for the preoperative assessment of wounds making a true
comparison of the included studies difficult. Twelve of the
eighteen studies gave information on the location of
wounds treated.13,14,16e18,20,21,23,24,26e28 Description of
wound location was given for 399 patients: 12% of wounds
treated were on the dorsum of the foot, 30% on the forefoot
or lateral aspect, 10% on the plantar aspect, 24% on the
heel, and 24% on the lower leg or ankle. One study com-
mented on the number of patients deemed unsalvageable
following evaluation.15 Hong et al. assessed 286 patients for
surgery and 215 failed the preoperative selection criteria.
71 of the 286 had foot reconstruction which equates to
24.8%. There was no comment from any study on the
denominator of ulcers and infected diabetic feet seen in
their practice or the number of local reconstructive
procedures done. All studies described debridement of
devitalised soft tissue and infected bone prior to free tissue
transfer. However, only two studies described the process
of debridement and free tissue transfer during the same
operation.15,16 Osteomyelitis was specifically mentioned in
thirteen studies.13e19,22e24,26e28 When described, 55% of
operated patients had osteomyelitis prior to debridement
and free tissue transfer.Good
diabetic
control
No major
systemic
illness
1 patent
below
knee artery
Biphasic or
triphasic
duplex
signal
Protective
sensation
intact
O
O
O O O O
O O O
O
O
O
Table 2 Pre-operative assessment conducted.
Study Patients
(N )
Angiogram Microbiology
swabs
Ultrasound
duplex
Foot
X-ray
Cardiac
thallium scan
CT
angio
PET bone
scan
ABPI
Czerny et al.27 25 O O
Drazan et al.30 13 O O O O
Gooden et al.14 26 O O O
Hong15 71 O O O O
Karp et al.16 19 O O O
Kim et al.28 15 O O O O
Lai et al.17 9 O O O
McCarthy et al.29 21 O O
Moran et al.18 75 O O O
Moucharafieh et al.19 10 O O
Oishi et al.20 19 O O
Ozkan et al.21 13 O O O O
Quin˜ones-Baldrich et al.22 15 O O
Rainer et al.23 10 O O O O
Randon et al.24 76 O O
Sunar et al.25 14 O O O
Tukiainen et al.13 79 O O
Verhelle et al.26 19 O O
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Four studies used only one flap type on all their
patients.15,17,25,28 Five studies gave specific details of which
flap was used for each type of defect encoun-
tered.16,17,23,26,28 Muscle flaps accounted for 63% of those
used, whilst fasciocutaneous flaps were used in 35% of
cases, and there were also 9 omental flaps from 3
studies13,18,29 (Table 3). Muscle flaps used were muscle only
with split skin graft covering. No studies clearly docu-
mented the use of a myocutaneous flap. The rectus muscle
flap was the commonest flap utilised by twelve studies,
accounting for 29% (n Z 161) of all flaps, whilst the series
by Hong of 71 cases accounted for the majority of antero-
lateral thigh flaps used. Flap anastomosis solely onto native
vessels in the foot was performed in 6 out of 18 stud-
ies.15e17,23,25,28 Five studies incorporated interposition vein
grafts to extend the pedicles for flap anastomosis. A total of
nine studies documented flap anastomosis directly onto
bypass vein grafts.13,14,18e20,22,26,29,30 Muscle flaps were
favoured in forefoot defects whilst heel defects had a near
equal muscle and fasciocutaneous flap use (Fig. 2).
Revascularisation
Seventeen studies utilised lower leg revascularisation for
peripheral arterial occlusive disease alongside free tissue
transfer, with 359 out of 543 (66%) patients having a lower
leg revascularisation procedure and 21 patients undergoing
angioplasty.13e20,22e30 Of the lower leg bypasses, 33% were
femoro-popliteal 26% popliteal-pedal, femoro-pedal 18%,
femoro-tibial 14%, and other procedures accounted for 9%.
Two studies incorporated 16 patients who had arteriovenous
fistulae created in the lower leg to provide vessels for the
transferred free tissue. In one study the AV fistula was
created specifically to provide an improved blood supply tothe transplanted flap,19 while in the other study it was used
as a flow-through fistula to provide a distal bypass and
vessels for the flap anastomosis.25 Of the 17 studies utilising
revascularisation, 13 authors chose to adopt a staged
approach.13,14,16e19,22,23,25,26,28e30 However only 6 of these
studies adopted a staged approach on all their
patients.16,23,25,26,28,30 There was data from only 6 of
these 17 studies on the length of time between revascular-
isation and free tissue transfer and this ranged from 9 to 60
days.13,14,18,22,25,26 Of the 17 studies that utilised revascular-
isation, 14 used autologous vein exclusively,14e19,22,24e27,29,30
2 used PTFE (polytetrafluoroethylene) only,23,28 and one
study incorporated the use of both autologous vein and
PTFE.
Mortality and morbidity
In-hospital mortality was reported in all 18 studies. 30-day
mortality was 3.9% (1.5e6.2, CI 95%. The minor complica-
tion rate such as wound infection, minor flap edge necrosis
and haematoma pooled across the studies was 34%
(20.8e48.5, CI 95%). The major complication rate such as
flap loss, amputation, MI and death, were 16% (10.2e21, CI
95%).
Flap survival rates
The combined average flap survival rate, was 91.9%
(87.5e96.1, CI 95%). Infectionwas thepredominant cause for
early flap loss. Of the successful flaps primary patency was
achieved in 86%. The remaining flaps were successfully
revised to achieve secondary patency. Reasons for a return to
theatre included haematoma, arterial and venous anasto-
mosis revision and partial flap necrosis requiring debride-
ment and skin grafting. There was no indication as to the
number of returns to theatre each of the successfully revised
Table 3 Types and numbers of flaps used.
Study Flap (n) Muscle Facsiocutaneous
TRAM Lat. Dorsi Gracilis Serratus Tensor FL ALT DIEP Radial
forearm
Scapular
/Parascapular
Lateral arm
/perforator
Temporoparietal Omental
Czerny et al.27 27 6 3 18 0 0 0 0 0 0 0 0 0
Drazan et al.30 13 3 8 0 1 0 0 0 1 0 0 0 0
Gooden et al.14 27 9 0 0 0 0 7 0 8 3 0 0 0
Hong15 71 0 0 0 0 0 71 0 0 0 0 0 0
Karp et al.16 21 6 6 0 0 0 0 0 2 6 0 1 0
Kim et al.28 15 0 0 0 0 0 15 0 0 0 0 0 0
Lai et al.17 10 0 0 10 0 0 0 0 0 0 0 0 0
McCarthy et al.29 21 5 5 2 0 0 0 0 3 1 0 0 5
Moran et al.18 79 35 15 0 0 0 0 0 24 3 0 0 2
Moucharafieh et al.19 10 7 1 0 0 0 0 0 1 1 0 0 0
Oishi et al.20 19 6 2 3 2 0 0 0 5 1 0 0 0
Ozkan et al.21 13 0 0 1 0 1 5 1 3 1 1 0 0
Quin˜ones-Baldrich
et al.22
15 5 8 1 0 0 0 0 1 0 0 0 0
Rainer et al.23 10 0 4 6 0 0 0 0 0 0 0 0 0
Randon et al.24 78 59 10 0 2 0 3 0 0 0 4 0 0
Sunar et al.25 14 0 14 0 0 0 0 0 0 0 0 0 0
Tukiainenet et al.13 81 19 45 2 1 2 0 0 10 0 0 0 2
Verhelle et al.26 19 1 3 0 4 1 0 0 9 0 0 1 0
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Figure 2 Number of flaps by type and defect location. TRAM Z Transverse rectus abdominis myocutaneous flap, Lat.
Dorsi Z Latissimus dorsi flap, Tensor FL Z Tensor fascia lata flap, ALT Z Anterolateral thigh flap, Temporo Z Temporoparietal
fascial flap.
396 E.J. Fitzgerald O’Connor et al.cases required, nor was there any data available on the time
perspective for the flaps which did fail.
Limb salvage rates and ambulation rates
All 18 studies reported limb salvage rate. The average was
83.4% (77.1e89.7, CI 95%) over a follow-up period ranging
from 1 to 68 months, with a pooled average follow-up time
of 28 months. Residual ulcers, and thus incomplete healing
in patients who were operated on and did not go on to have
an amputation by the end points of observation, were
noted in 2 patients across all studies. Thus, complete
wound healing was achieved in 99% of successful free tissue
transfers. Sixteen studies published an ambulation rate
with a mean rate of 76% (69.8e83.9, CI 95%). One study
noted that average time to weight-bearing was 3.5 weeks
and 6 weeks for bipedal ambulation.15 The presence of
transfer ulceration was specifically mentioned in one study,
2 out of 10 patients developed an ulcer on the operated
foot far from the flap area, and both were healed with
conservative treatment.19
Discussion
This systematic review has demonstrated that excellent
rates of wound healing and limb preservation are achievable
in highly specialised units using free flaps in selected
patients with diabetes and non-traumatic lower limb
wounds. The pooled flap survival rate of 91.9% in this pop-
ulation of patients is comparable to one of the largest case
series (flap success rate 99%) incorporating over one thou-
sand free flaps for a range of defects including breast
reconstruction, cancer and trauma.31 The studies presentedhere demonstrate the total published evidence of global
experience. However, when compared to global diabetic
lower limb amputation figures there is a large difference.
This may reflect a reluctance to routinely perform this type
of surgery, the limited availability of specialist reconstruc-
tive ambulation skills or the unfamiliarity of the treating
doctor with free tissue transfer reconstructive options.
The proportion of patients who might benefit from free
flaps to heal their wounds remains uncertain. There are
10,000 major amputations performed every year in the UK
for diabetes.32 At present the numbers of free flaps per-
formed worldwide, according to the literature, are low and
appear to be restricted to enthusiastic, highly specialised
centres. However, there may be an unmet need. The data
from Hong suggested that 25% of patients with complex
diabetic foot ulcers may be suitable for free flap surgery,
whilst the studies included in this review demonstrated
units were operating on an average of 6e7 patients a year.
Including a plastic surgeon with expertise in free flap
reconstruction in the multidisciplinary diabetic foot team
might save limbs previously deemed unsalvageable. Clearly
significant peripheral vascular disease is highly prevalent
within the cohort under analysis, with 66% of patients
undergoing some form of bypass surgery prior to free tissue
transfer. Unfortunately there was little granularity on the
specific outcomes of diabetic and non-diabetic neuro-
ischaemic ulcers. In the general management of ulcers,
neuroischaemic ulcers, are widely associated with poorer
outcome when compared to isolated neuropathic ulcers.33
Future studies could elucidate the difference, if any, in
the outcomes between these groups.
Guidelines on the management of diabetic foot wounds
have been produced34 but, at present, there is little data to
support the use of more complex treatment adjuncts, such
Table 4 Baseline pre-operative workup.
1. Adequate debridement of necrotic and infected tissue
2. Microbiological assessment and appropriate antibiotic
regimen
3. Lower limb angiography CT angiography for flap donor
site planning
4. Appropriate anaesthetic assessment of cardiovascular
and respiratory systems
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healing. The use of VAC (Vacuum Assisted Closure) has
increased markedly in the management of all wounds,
including those of the lower extremity, in patients with
diabetes. There is little doubt that this technique can be
used in the management of large complex wounds.
However, the evidence to support the use of VAC therapy in
the management of diabetic lower extremity wounds is
thin.35e37 Indeed, in the UK, current NICE (National Insti-
tute for Health and Clinical Excellence) guidance is that
VAC should only be used within the context of a clinical
trial.38 There is no data to suggest that the use of VAC has
had an influence on the number of free flaps performed for
lower limb reconstruction nor on the number of amputa-
tions performed. Furthermore the role of topical negative
pressure dressings in the cohort of patients under review
may be limited. Negative pressure healing requires an
adequate vascular supply, something lacking in a large
proportion of patients with diabetes. Specifically, in lower
leg ulcers vacuum assisted healing has the disadvantage of
being unable to be used over any vascular reconstruction
and presents a challenge when used over a weight-bearing
surface. The longer healing time seen using negative pres-
sure dressings when compared to free flap cover is also an
important consideration when determining the optimum
treatment modality. Therefore given the potentially
excellent results, clinicians should be considering the use of
free flaps more often in the management of large complex
wounds.
The available data on patient selection suggested all
patients were considered for free flaps only when faced
with an amputation with all conservative and local recon-
structive options exhausted. Three studies stipulated that
patients must have been ambulatory prior to limb
compromise20,23,26 and have stable glycaemic control.
Arterial inflow assessment using ultrasonography was
deemed necessary in 2 studies where patients were
required to have biphasic or triphasic patterns on lower leg
arterial assessment.16,23 The evidence for the role of peak
blood flow velocity (PBFV) correlation with flap survival is
weak, only one study assessed this variable.28 This study
showed that survival of transferred tissue was strongly
associated with a PBFV of greater than 40 cm/s. All studies
utilised angiography prior to surgery, and currently there is
no evidence to base any decision on ultrasound duplex
alone. However the role for pre-operative ultrasound may
lie in PBFV values and the future data on their correlation
with successful tissue transfer.
Interestingly only 4 of the 18 studies included the
criterion that patients must have no major systemic illness.
Renal disease is an identified risk factor in free flap
failure,39 uraemia can impair wound healing, whilst the
anticoagulation required for dialysis increases the risks of
haematoma formation. Renal disease is also a significant
risk factor in lower limb bypass surgery and amputation, not
only for postoperative complications but also mortality.40
Renal failure was mentioned specifically in only 2 of the
18 studies. One study demonstrated that renal failure was
a strong predictor of limb loss.24 In the cohort of patients
under examination, however, these comorbidities are
widely prevalent and so total exclusion would leave you
with, a very small treatable population.As part of the patient selection, pre-operative assess-
ment and optimisation is a key factor to operative success.
All 528 patients underwent preoperative angiography. Only
one study described the total number of patients assessed
for free tissue reconstruction and deemed unsalvageable.15
None of the other studies elucidated the number of
patients assessed for free tissue transfer who were then
deemed unsalvageable and went on to have an amputation.
Evidence on the number of patients deemed unsalvageable
and the reasons why, would aid future patient selection
decisions. This highlights the pressing need for an MDT
approach to patient selection, incorporating the expertise
from Plastic Surgeons, Vascular Surgeons, Anaesthetists,
Endocrinologists, Microbiologists, Podiatrists, and
Physiotherapists.
Unfortunately none of the studies conformed to the
STROBE guidelines41 and there were no standard reporting
criteria and no validated diabetic ulcer scoring systems
quoted. It was therefore difficult to compare studies
directly. Key improvements in reporting could have been
made with the authors quoting healed wounds instead of
limb salvage, which is not a particularly useful term in
patients with diabetic foot complications. Following
successful free tissue transfer, one can argue that the ulcer
wound is healed however, due to significant recurrence
rates in diabetic ulcers data on reulceration in the surgical
cohort would have been beneficial. Limb salvage does not
also encapsulate the usefulness of the limb. Similarly
greater data on mobility, ambulation and transfer ulcera-
tion would have been helpful.
Of the flaps that failed, infection was the predominant
cause. In contrast, studies of free flaps for other indications
suggest that anastomotic failure and thrombosis are the
leading causes of failure. Given the rate of preoperative
osteomyelitis in the studies of 55%, the risk of residual deep
seated infection is likely to have contributed to this source
of flap failure. All efforts at eradication of osteomyelitis
should be viewed as a priority, either via the use of surgery
or antibiotics.
The variability in the choice of donor site tissue reflects
the evolution in free tissue transfer surgery, and the
advances in donor site morbidity management (Table 3).
63% were muscle flaps, with 35% being fasciocutaneous
flaps. Traditionally muscle flaps with skin grafts are
perceived to be more stable than fasciocutaneous flaps as
they can provide closer approximation to foot contours.42 In
the diabetic population the added benefit of muscle flaps
could be associated with the increased vascularity of the
flap which may provide better infection control. However,
the position of a muscle flap on weight-bearing surfaces
was shown in one study to be associated with higher
Table 5 Suggested inclusion criteria.
1. Lower limb defect which has not displayed any signs of
granulation or healing despite adequate debridement
of necrotic tissue and conservative treatment
2. No significant renal function impairment
3. No significant systemic illness likely to be exacerbated
by multiple operations and prolonged rehabilitation
4. Previously ambulatory with the aim to restore a func-
tional limb
5. Likely to engage with the significant physiotherapy
required for a return to normal living.
6. Peak blood flow velocity of >40 cm/s in recipient artery
398 E.J. Fitzgerald O’Connor et al.incidences of recurrent ulceration and extended time to
weight-bearing status.15 Thinned fasciocutaneous flaps
provide less bulk to a defect and have the advantage that
they can be innervated.43,44 These thinner flaps may also
reduce the shearing forces often seen with thicker flaps.15
Consideration must also be given to the donor site wound
and potential for complications, as seen in other studies
involving patients with diabetes and tissue donor sites.45
Ankle- brachial pressure index was used in 4 studies, as part
of the pre-operative assessment and selection. Values of
greater than 0.6 were selected as the cutoff for inclusion. This
figure has been chosen from an early case series in the litera-
ture,46 however, given the known fact that diabetes is linked to
increased calcification in peripheral arteries, ABPI readings are
often erroneously elevated. The inaccuracy in ABPI measure-
ments would suggest its use as a marker for perfusion and flap
success may be highly limited. Pre-hospitalization ambulation
was an inclusion criterion in 8 studies,13,14,18,20,23e26 demon-
strating the goal for this form of limb salvage surgery.
Free tissue transfers in the diabetic population could
possibly provide ancillary benefits apart from skin
coverage. The transplantation of a low resistance vascular
bed onto a bypass outflow has been demonstrated to
prolong the bypass graft survival,47,48 however, one study
reported microvascular steal phenomenon in 3 of 10
cases.23 In diabetic patients with lower leg peripheral
occlusive disease, flow to the foot is compromised and
provided often by collateral circulation or stenotic vessels.
Following free tissue transfer, flow may be preferentially
diverted through the low resistance vascular bed of the new
flap thus denying adequate perfusion to the high resistance
diseased vascular bed, leading to progressive ischemia.49
This is a strong argument to combine free flap transfer
with revascularisation to improve inflow. Steal phenomenon
can indeed only occur when inflow is the limiting factor.
This possible complication provides further consideration
when planning surgery.
In conclusion, free tissue transfer achieves successful
wound healing in selected patients with diabetes and diffi-
cult to heal wounds that would otherwise have been treated
by amputation. In order to ascertainwhich patients are likely
to benefit from this form of limb saving surgery it is vital to
use established scoring systems, when reporting data to
allow meaningful analysis of outcomes. None of the pooled
studies utilised scoring systems thus a correlation of
successful free tissue transfer for specific defects was not
available. Pre-operative optimisation of vascular supply anderadication of infection is vital to success (Table 4). Fas-
ciocutaneous and muscle flaps may be used and each have
their merits. Further work is required to identify how many
patients may benefit from free tissue transfer and a plastic
surgeon experienced in this technique should be included in
the multidisciplinary diabetic foot team (Table 5).
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